Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.68
CI's Cash-to-Debt is ranked lower than
67% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.51 vs. CI: 0.68 )
Ranked among companies with meaningful Cash-to-Debt only.
CI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.28  Med: 0.76 Max: 2.11
Current: 0.68
0.28
2.11
Equity-to-Asset 0.23
CI's Equity-to-Asset is ranked lower than
77% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.34 vs. CI: 0.23 )
Ranked among companies with meaningful Equity-to-Asset only.
CI' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.05  Med: 0.12 Max: 0.24
Current: 0.23
0.05
0.24
Debt-to-Equity 0.38
CI's Debt-to-Equity is ranked higher than
74% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.55 vs. CI: 0.38 )
Ranked among companies with meaningful Debt-to-Equity only.
CI' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01  Med: 0.29 Max: 0.67
Current: 0.38
0.01
0.67
Debt-to-EBITDA 1.25
CI's Debt-to-EBITDA is ranked higher than
79% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.05 vs. CI: 1.25 )
Ranked among companies with meaningful Debt-to-EBITDA only.
CI' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.98  Med: 1.28 Max: 3.82
Current: 1.25
0.98
3.82
Interest Coverage 14.04
CI's Interest Coverage is ranked higher than
58% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.39 vs. CI: 14.04 )
Ranked among companies with meaningful Interest Coverage only.
CI' s Interest Coverage Range Over the Past 10 Years
Min: 8.06  Med: 10.67 Max: 14.04
Current: 14.04
8.06
14.04
Beneish M-Score: -2.71
WACC vs ROIC
4.55%
15.50%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 8.42
CI's Operating Margin % is ranked higher than
77% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.13 vs. CI: 8.42 )
Ranked among companies with meaningful Operating Margin % only.
CI' s Operating Margin % Range Over the Past 10 Years
Min: 2  Med: 8.56 Max: 10.31
Current: 8.42
2
10.31
Net Margin % 5.73
CI's Net Margin % is ranked higher than
73% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.24 vs. CI: 5.73 )
Ranked among companies with meaningful Net Margin % only.
CI' s Net Margin % Range Over the Past 10 Years
Min: 1.53  Med: 5.67 Max: 7.07
Current: 5.73
1.53
7.07
ROE % 16.66
CI's ROE % is ranked higher than
58% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.08 vs. CI: 16.66 )
Ranked among companies with meaningful ROE % only.
CI' s ROE % Range Over the Past 10 Years
Min: 7  Med: 18.32 Max: 28.9
Current: 16.66
7
28.9
ROA % 3.86
CI's ROA % is ranked lower than
59% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.31 vs. CI: 3.86 )
Ranked among companies with meaningful ROA % only.
CI' s ROA % Range Over the Past 10 Years
Min: 0.72  Med: 2.98 Max: 3.86
Current: 3.86
0.72
3.86
3-Year Revenue Growth Rate 10.20
CI's 3-Year Revenue Growth Rate is ranked lower than
52% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. CI: 10.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CI' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 4.7 Max: 18.4
Current: 10.2
0
18.4
3-Year EBITDA Growth Rate 11.30
CI's 3-Year EBITDA Growth Rate is ranked lower than
55% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.60 vs. CI: 11.30 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CI' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 8.7 Max: 104.7
Current: 11.3
0
104.7
3-Year EPS without NRI Growth Rate 11.50
CI's 3-Year EPS without NRI Growth Rate is ranked higher than
68% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.40 vs. CI: 11.50 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CI' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -32  Med: 6.6 Max: 79.9
Current: 11.5
-32
79.9
GuruFocus has detected 6 Warning Signs with Cigna Corp CI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CI's 30-Y Financials

Financials (Next Earnings Date: 2018-02-01)


Revenue & Net Income
Equity & Asset
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

CI Guru Trades in Q4 2016

Paul Tudor Jones 3,800 sh (New)
Jim Simons 462,900 sh (New)
Lee Ainslie 2,013,625 sh (+341.31%)
George Soros 36,902 sh (+183.86%)
Richard Pzena 2,317,548 sh (+155.76%)
Joel Greenblatt 27,831 sh (+48.96%)
Steven Cohen 228,700 sh (+18.50%)
Keeley Asset Management Corp 14,120 sh (+10.92%)
Vanguard Health Care Fund 7,804,631 sh (+3.60%)
Dodge & Cox 14,465,358 sh (+0.11%)
Mario Gabelli 15,000 sh (unchged)
David Einhorn 435,000 sh (unchged)
Eric Mindich 500,000 sh (unchged)
Pioneer Investments 18,887 sh (unchged)
Barrow, Hanley, Mewhinney & Strauss 2,012,803 sh (-2.16%)
Mairs and Power 4,500 sh (-4.15%)
Larry Robbins 5,662,086 sh (-5.50%)
NWQ Managers 430,840 sh (-6.49%)
David Dreman 39 sh (-86.22%)
» More
Q1 2017

CI Guru Trades in Q1 2017

Alan Fournier 322,500 sh (New)
Paul Tudor Jones 25,886 sh (+581.21%)
Jim Simons 658,900 sh (+42.34%)
Lee Ainslie 2,456,819 sh (+22.01%)
Joel Greenblatt 33,158 sh (+19.14%)
Vanguard Health Care Fund 7,804,631 sh (unchged)
David Einhorn 435,000 sh (unchged)
Mairs and Power 4,500 sh (unchged)
Pioneer Investments 18,887 sh (unchged)
David Dreman Sold Out
George Soros Sold Out
Steven Cohen Sold Out
Dodge & Cox 14,399,578 sh (-0.45%)
Barrow, Hanley, Mewhinney & Strauss 1,974,863 sh (-1.88%)
Richard Pzena 2,256,353 sh (-2.64%)
NWQ Managers 416,144 sh (-3.41%)
Larry Robbins 4,905,428 sh (-13.36%)
Mario Gabelli 10,650 sh (-29.00%)
» More
Q2 2017

CI Guru Trades in Q2 2017

Steven Cohen 141,900 sh (New)
David Dreman 39 sh (New)
Mairs and Power 4,559 sh (+1.31%)
Barrow, Hanley, Mewhinney & Strauss 1,979,077 sh (+0.21%)
Pioneer Investments 18,887 sh (unchged)
David Einhorn Sold Out
Dodge & Cox 13,909,629 sh (-3.40%)
NWQ Managers 395,860 sh (-4.87%)
Vanguard Health Care Fund 6,889,431 sh (-11.73%)
Jim Simons 555,100 sh (-15.75%)
Richard Pzena 1,783,177 sh (-20.97%)
Alan Fournier 250,900 sh (-22.20%)
Larry Robbins 3,743,184 sh (-23.69%)
Lee Ainslie 1,447,984 sh (-41.06%)
Mario Gabelli 6,050 sh (-43.19%)
Paul Tudor Jones 13,580 sh (-47.54%)
Joel Greenblatt 16,044 sh (-51.61%)
» More
Q3 2017

CI Guru Trades in Q3 2017

George Soros 76,800 sh (New)
Joel Greenblatt 34,946 sh (+117.81%)
Pioneer Investments 18,887 sh (unchged)
Mairs and Power 4,559 sh (unchged)
David Dreman 39 sh (unchged)
Jim Simons Sold Out
Paul Tudor Jones Sold Out
Barrow, Hanley, Mewhinney & Strauss 1,963,690 sh (-0.78%)
Dodge & Cox 13,008,253 sh (-6.48%)
Vanguard Health Care Fund 6,235,689 sh (-9.49%)
Alan Fournier 218,800 sh (-12.79%)
Larry Robbins 3,083,753 sh (-17.62%)
Richard Pzena 1,350,411 sh (-24.27%)
Mario Gabelli 4,050 sh (-33.06%)
NWQ Managers 264,719 sh (-33.13%)
Steven Cohen 69,700 sh (-50.88%)
Lee Ainslie 111,800 sh (-92.28%)
» More
» Details

Insider Trades

Latest Guru Trades with CI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Dodge & Cox 2017-09-30 Reduce -6.48%0.13%$167.5 - $187.62 $ 209.9718%13,008,253
Vanguard Health Care Fund 2017-09-30 Reduce -9.49%0.24%$167.5 - $187.62 $ 209.9718%6,235,689
Barrow, Hanley, Mewhinney & Strauss 2017-09-30 Reduce -0.78%$167.5 - $187.62 $ 209.9718%1,963,690
Richard Pzena 2017-09-30 Reduce -24.27%0.4%$167.5 - $187.62 $ 209.9718%1,350,411
NWQ Managers 2017-09-30 Reduce -33.13%0.3%$167.5 - $187.62 $ 209.9718%264,719
George Soros 2017-09-30 New Buy0.43%$167.5 - $187.62 $ 209.9718%76,800
Joel Greenblatt 2017-09-30 Add 117.81%0.05%$167.5 - $187.62 $ 209.9718%34,946
Mario Gabelli 2017-09-30 Reduce -33.06%$167.5 - $187.62 $ 209.9718%4,050
Dodge & Cox 2017-06-30 Reduce -3.40%0.06%$146.49 - $170.68 $ 209.9731%13,909,629
Vanguard Health Care Fund 2017-06-30 Reduce -11.73%0.3%$146.49 - $170.68 $ 209.9731%6,889,431
Barrow, Hanley, Mewhinney & Strauss 2017-06-30 Add 0.21%$146.49 - $170.68 $ 209.9731%1,979,077
Richard Pzena 2017-06-30 Reduce -20.97%0.39%$146.49 - $170.68 $ 209.9731%1,783,177
NWQ Managers 2017-06-30 Reduce -4.87%0.04%$146.49 - $170.68 $ 209.9731%395,860
Joel Greenblatt 2017-06-30 Reduce -51.61%0.03%$146.49 - $170.68 $ 209.9731%16,044
Mario Gabelli 2017-06-30 Reduce -43.19%$146.49 - $170.68 $ 209.9731%6,050
David Dreman 2017-06-30 New Buy$146.49 - $170.68 $ 209.9731%39
David Einhorn 2017-06-30 Sold Out 0.89%$146.49 - $170.68 $ 209.9731%0
Dodge & Cox 2017-03-31 Reduce -0.45%0.01%$135.72 - $154 $ 209.9742%14,399,578
Richard Pzena 2017-03-31 Reduce -2.64%0.05%$135.72 - $154 $ 209.9742%2,256,353
Barrow, Hanley, Mewhinney & Strauss 2017-03-31 Reduce -1.88%0.01%$135.72 - $154 $ 209.9742%1,974,863
NWQ Managers 2017-03-31 Reduce -3.41%0.03%$135.72 - $154 $ 209.9742%416,144
Joel Greenblatt 2017-03-31 Add 19.14%0.01%$135.72 - $154 $ 209.9742%33,158
Mario Gabelli 2017-03-31 Reduce -29.00%$135.72 - $154 $ 209.9742%10,650
George Soros 2017-03-31 Sold Out 0.16%$135.72 - $154 $ 209.9742%0
David Dreman 2017-03-31 Sold Out $135.72 - $154 $ 209.9742%0
Dodge & Cox 2016-12-31 Add 0.11%$116.03 - $140 $ 209.9760%14,465,358
Vanguard Health Care Fund 2016-12-31 Add 3.60%0.09%$116.03 - $140 $ 209.9760%7,804,631
Richard Pzena 2016-12-31 Add 155.76%1.07%$116.03 - $140 $ 209.9760%2,317,548
Barrow, Hanley, Mewhinney & Strauss 2016-12-31 Reduce -2.16%0.01%$116.03 - $140 $ 209.9760%2,012,803
NWQ Managers 2016-12-31 Reduce -6.49%0.06%$116.03 - $140 $ 209.9760%430,840
George Soros 2016-12-31 Add 183.86%0.1%$116.03 - $140 $ 209.9760%36,902
Joel Greenblatt 2016-12-31 Add 48.96%0.02%$116.03 - $140 $ 209.9760%27,831
Keeley Asset Management Corp 2016-12-31 Add 10.92%0.01%$116.03 - $140 $ 209.9760%14,120
David Dreman 2016-12-31 Reduce -86.22%0.02%$116.03 - $140 $ 209.9760%39
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 524114    SIC: 6324
Compare:NYSE:ANTM, NYSE:AET, NAS:ESRX, NYSE:HUM, NYSE:CVS, NYSE:CNC, NYSE:WCG, NYSE:MOH, BSP:QUAL3, BSP:ODPV3, NAS:MGLN, XPAR:GDS, NAS:HIIQ, OSTO:MCOV B, ATH:IATR, ASX:ONT, OTCPK:HFRN, MIL:HI, OTCPK:OPRX, OSTO:FEEL » details
Traded in other countries:CGN.Germany,
Headquarter Location:USA
Cigna Corp operates in the healthcare industry. It provides medical, dental, disability, life and accident insurance products.

Cigna is one of the largest managed-care organizations in the United States, with a little over 14 million medical members. The firm provides health insurance services to individuals mainly through the group (employer) market. Cigna is one of the leaders in the commercial self-funded fee market, which is where most of the growth has and will continue to come from for the large-group segment. The firm also participates in other insurance and retirement businesses that make up a material portion of its total operations.

Top Ranked Articles about Cigna Corp

Market Trends Toward New Normal in U.S., Becton, Dickinson, Cigna, Aetna, Enphase Energy, and Vishay Intertechnology — Emerging Consolidated Expectations, Analyst Ratings
Glenview Capital Sells Lowe, Visa, Walgreens, Exits Humana Larry Robbins’ largest 3rd-quarter sales
Glenview Capital Management was founded and is managed by hedge fund billionaire Larry Robbins (Trades, Portfolio). The fund reported solid returns in the last year. The performance of the first six months of 2017 is up 14.8% compared to 9.3% for the S&P 500 Index. During the same period its assets value has risen to $11.5 billion. The following stocks were sold during the third quarter. Read more...
Vanguard Health Care Fund Trims Positions in Vertex, Regeneron, Illumina Fund's largest 3rd-quarter sales
Founded in 1984, the Vanguard Health Care Fund (Trades, Portfolio) is managed by Jean Hynes. During the third quarter, the fund reduced its positions in the following stocks: Read more...
New Research Coverage Highlights Cigna, Thermo Fisher Scientific, Raytheon, W. W. Grainger, Waters, and Cummins – Consolidated Revenues, Company Growth, and Expectations for 2018
2017 Cigna 360° Well-being Survey - Positive Aspects of Working Overseas Often Overshadowed by Health and Financial Concerns
America's Favorite TV Doctors Scrub Up to Join Cigna In Campaign Promoting Preventive Care, Helping to Save Lives
5 Companies Reach 52-Week Highs Exelon, Baxalta, Home Depot, Cigna, Stanley Black & Decker achieve milestones
According to GuruFocus' list, these stocks have reached their 52-week highs. Read more...
Bisk Honored with 2017 Cigna Well-Being Award
David Einhorn Starts Hewlett Packard Enterprise Position in 2nd Quarter Most of guru’s transactions are sells
David Einhorn (Trades, Portfolio), president of Greenlight Capital, seeks long-term capital appreciation through investments that have the potential to achieve consistent returns and safeguard capital. During the second quarter, the activist investor entered a position in Hewlett Packard Enterprise Co. (NYSE:HPE) and eliminated four positions from his portfolio: Time Warner Inc. (NYSE:TWX), Liberty Global PLC (NASDAQ:LBTYK), Syngenta AG (NYSE:SYT) and Cigna Corp. (NYSE:CI). Read more...
Richard Pzena Curbs Cigna, Abbott Labs, Bank of America Stakes Guru's 8 largest 2nd-quarter sells
Richard Pzena (Trades, Portfolio), founder and co-chief investment officer of Pzena Investment Management, sold shares of the following stocks during the second quarter: Read more...

Ratios

vs
industry
vs
history
PE Ratio 23.00
CI's PE Ratio is ranked lower than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.90 vs. CI: 23.00 )
Ranked among companies with meaningful PE Ratio only.
CI' s PE Ratio Range Over the Past 10 Years
Min: 3.25  Med: 13.34 Max: 23.11
Current: 23
3.25
23.11
Forward PE Ratio 18.62
CI's Forward PE Ratio is ranked lower than
55% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.85 vs. CI: 18.62 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 23.00
CI's PE Ratio without NRI is ranked lower than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 20.71 vs. CI: 23.00 )
Ranked among companies with meaningful PE Ratio without NRI only.
CI' s PE Ratio without NRI Range Over the Past 10 Years
Min: 3.25  Med: 13.27 Max: 23.11
Current: 23
3.25
23.11
Price-to-Owner-Earnings 13.80
CI's Price-to-Owner-Earnings is ranked higher than
50% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.97 vs. CI: 13.80 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CI' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.21  Med: 10.46 Max: 541.12
Current: 13.8
2.21
541.12
PB Ratio 3.71
CI's PB Ratio is ranked lower than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.89 vs. CI: 3.71 )
Ranked among companies with meaningful PB Ratio only.
CI' s PB Ratio Range Over the Past 10 Years
Min: 0.52  Med: 2.23 Max: 3.96
Current: 3.71
0.52
3.96
PS Ratio 1.33
CI's PS Ratio is ranked lower than
68% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.58 vs. CI: 1.33 )
Ranked among companies with meaningful PS Ratio only.
CI' s PS Ratio Range Over the Past 10 Years
Min: 0.13  Med: 0.68 Max: 1.34
Current: 1.33
0.13
1.34
Price-to-Free-Cash-Flow 13.77
CI's Price-to-Free-Cash-Flow is ranked higher than
56% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.51 vs. CI: 13.77 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CI' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 1.8  Med: 12.2 Max: 148
Current: 13.77
1.8
148
Price-to-Operating-Cash-Flow 12.43
CI's Price-to-Operating-Cash-Flow is ranked higher than
55% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.80 vs. CI: 12.43 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CI' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.51  Med: 9.33 Max: 36.49
Current: 12.43
1.51
36.49
EV-to-EBIT 14.43
CI's EV-to-EBIT is ranked higher than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.46 vs. CI: 14.43 )
Ranked among companies with meaningful EV-to-EBIT only.
CI' s EV-to-EBIT Range Over the Past 10 Years
Min: -1.6  Med: 8.5 Max: 17.6
Current: 14.43
-1.6
17.6
EV-to-EBITDA 12.52
CI's EV-to-EBITDA is ranked lower than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.98 vs. CI: 12.52 )
Ranked among companies with meaningful EV-to-EBITDA only.
CI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1.4  Med: 7.1 Max: 12.6
Current: 12.52
-1.4
12.6
EV-to-Revenue 1.30
CI's EV-to-Revenue is ranked lower than
69% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.83 vs. CI: 1.30 )
Ranked among companies with meaningful EV-to-Revenue only.
CI' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.1  Med: 0.7 Max: 1.3
Current: 1.3
-0.1
1.3
PEG Ratio 1.84
CI's PEG Ratio is ranked higher than
54% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.73 vs. CI: 1.84 )
Ranked among companies with meaningful PEG Ratio only.
CI' s PEG Ratio Range Over the Past 10 Years
Min: 0.24  Med: 0.91 Max: 28.18
Current: 1.84
0.24
28.18
Shiller PE Ratio 34.24
CI's Shiller PE Ratio is ranked lower than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 25.17 vs. CI: 34.24 )
Ranked among companies with meaningful Shiller PE Ratio only.
CI' s Shiller PE Ratio Range Over the Past 10 Years
Min: 3.12  Med: 17.15 Max: 34.42
Current: 34.24
3.12
34.42

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.02
CI's Dividend Yield % is ranked lower than
100% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.41 vs. CI: 0.02 )
Ranked among companies with meaningful Dividend Yield % only.
CI' s Dividend Yield % Range Over the Past 10 Years
Min: 0.02  Med: 0.07 Max: 0.57
Current: 0.02
0.02
0.57
Forward Dividend Yield % 0.02
CI's Forward Dividend Yield % is ranked lower than
100% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.53 vs. CI: 0.02 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.02
CI's 5-Year Yield-on-Cost % is ranked lower than
100% of the 40 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.99 vs. CI: 0.02 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CI' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.02  Med: 0.07 Max: 0.57
Current: 0.02
0.02
0.57
3-Year Average Share Buyback Ratio 2.30
CI's 3-Year Average Share Buyback Ratio is ranked higher than
71% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.30 vs. CI: 2.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -5.8  Med: 3.2 Max: 11.7
Current: 2.3
-5.8
11.7

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 6.38
CI's Price-to-Tangible-Book is ranked higher than
74% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. CI: 6.38 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.72  Med: 3.43 Max: 28
Current: 6.38
0.72
28
Price-to-Intrinsic-Value-Projected-FCF 1.24
CI's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
56% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.19 vs. CI: 1.24 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CI' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.28  Med: 0.78 Max: 1.5
Current: 1.24
0.28
1.5
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.32
CI's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
67% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.51 vs. CI: 1.32 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
CI' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 1.02  Med: 1.1 Max: 1.17
Current: 1.32
1.02
1.17
Price-to-Median-PS-Value 1.93
CI's Price-to-Median-PS-Value is ranked lower than
92% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.10 vs. CI: 1.93 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CI' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.36  Med: 1.11 Max: 3.85
Current: 1.93
0.36
3.85
Price-to-Peter-Lynch-Fair-Value 2.33
CI's Price-to-Peter-Lynch-Fair-Value is ranked lower than
64% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.62 vs. CI: 2.33 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CI' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.35  Med: 0.67 Max: 2.96
Current: 2.33
0.35
2.96
Price-to-Graham-Number 2.55
CI's Price-to-Graham-Number is ranked higher than
75% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.10 vs. CI: 2.55 )
Ranked among companies with meaningful Price-to-Graham-Number only.
CI' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.44  Med: 1.4 Max: 3.75
Current: 2.55
0.44
3.75
Earnings Yield (Greenblatt) % 6.98
CI's Earnings Yield (Greenblatt) % is ranked higher than
67% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.07 vs. CI: 6.98 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CI' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -127  Med: 11.55 Max: 133.7
Current: 6.98
-127
133.7
Forward Rate of Return (Yacktman) % 13.82
CI's Forward Rate of Return (Yacktman) % is ranked lower than
53% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.68 vs. CI: 13.82 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CI' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -2.3  Med: 19.1 Max: 51.1
Current: 13.82
-2.3
51.1

More Statistics

Revenue (TTM) (Mil) $41,029.00
EPS (TTM) $ 9.13
Beta0.38
Short Percentage of Float1.27%
52-Week Range $131.03 - 207.21
Shares Outstanding (Mil)246.55

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 40,728 43,385 48,136
EPS ($) 9.94 11.33 12.98
EPS without NRI ($) 9.94 11.33 12.98
EPS Growth Rate
(Future 3Y To 5Y Estimate)
12.21%
Dividends per Share ($) 0.01 0.01

Piotroski F-Score Details

Piotroski F-Score: ----
Positive ROAN
Positive CFROAN
Higher ROA yoyN
CFROA > ROAN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}